Alimera Sciences

Press Releases

All Releases
View Summary Alimera Sciences to Hold Conference Call to Discuss First Quarter 2010 Financial Results
May 26, 2010
PDF 10.5 KB Add to Briefcase
View Summary Alimera Sciences to Present at Citi 2010 Global Health Care Conference
May 20, 2010
PDF 10.8 KB Add to Briefcase
View Summary Alimera Sciences Prices Initial Public Offering
Apr 23, 2010
PDF 12.8 KB Add to Briefcase
View Summary Alimera Announces Positive Results from the Two Phase 3 Fame™ Trials of Iluvien® in Patients with Diabetic Macular Edema
Dec 23, 2009
PDF 15.1 KB Add to Briefcase
View Summary Alimera Reports Safety And Efficacy Results From The 18-Month Interim Readout Of The Human PK Iluvien® Study
Sep 29, 2009
PDF 11.9 KB Add to Briefcase
View Summary Alimera Sciences Begins Pilot Study Of Iluvien in Patients With Macular Edema Secondary To Retinal Vein Occlusion
Sep 23, 2009
PDF 10.3 KB Add to Briefcase
View Summary Alimera Sciences Closes $5 Million In Extended Series C Financing
Aug 27, 2009
PDF 10.0 KB Add to Briefcase
View Summary Alimera Sciences Announces Presentation Of Data From The 12-Month Interim Readout Of The Human PK ILUVIEN™ Study At ARVO 2009 Annual Meeting
May 4, 2009
PDF 9.9 KB Add to Briefcase
View Summary Alimera Sciences’ Iluvien™ Phase 3 Studies For DME Pass Final DSMB Review Prior To October Readout
Apr 8, 2009
PDF 10.5 KB Add to Briefcase
View Summary Alimera Reports Favorable Safety And Efficacy Results From The 12-Month Interim Readout Of The Human PK Iluvien™ Study
Mar 12, 2009
PDF 12.1 KB Add to Briefcase
View Summary Alimera Sciences Begins Pilot Study To Assess Safety and Efficacy of Iluvien™ In Patients With Bilateral Geographic Atrophy Due To AMD
Dec 11, 2008
PDF 10.4 KB Add to Briefcase
View Summary Alimera Reports Results from the Six-Month Interim Readout of the Human PK Iluvien™ Study
Oct 1, 2008
PDF 10.9 KB Add to Briefcase
View Summary DSMB Again Supports Continuation of Alimera Sciences’ Phase 3 Clinical Trial of Iluvien™ for the Treatment of DME
Sep 24, 2008
PDF 10.7 KB Add to Briefcase
View Summary Alimera Reports Results from the Three-Month Interim Readout of the Human PK Medidur™ FA Study
Jun 26, 2008
PDF 12.3 KB Add to Briefcase
View Summary Pilot Study to Assess Safety and Efficacy of Medidur™ FA in AMD Patients Treated With Lucentis®
May 8, 2008
PDF 10.7 KB Add to Briefcase
View Summary DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur™ FA for the Treatment of DME
Mar 24, 2008
PDF 10.8 KB Add to Briefcase
View Summary Alimera Sciences Closes $30 Million In Series C Financing, Increasing Stake In Medidur™ FA
Mar 18, 2008
PDF 11.0 KB Add to Briefcase
View Summary Alimera Sciences, pSivida Limited Amend Medidur™ FA Collaboration Agreement
Mar 17, 2008
PDF 14.1 KB Add to Briefcase
View Summary 2008 Press Releases Alimera Sciences Signs Second Agreement With Emory University for Potential Treatments Using New Class of Antioxidants
Feb 26, 2008
PDF 12.5 KB Add to Briefcase
View Summary DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur™ FA for the Treatment of DME
Oct 17, 2007
PDF 14.6 KB Add to Briefcase
Showing 181-200 of 205 Page: 1 ... 6 7 8 9 10 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
/* */